Home » Stocks » BiondVax Pharmaceuticals

BiondVax Pharmaceuticals Ltd. (BVXV)

Stock Price: $32.83 USD -0.60 (-1.79%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 378.22M
Revenue (ttm) n/a
Net Income (ttm) -32.06M
Shares Out 11.53M
EPS (ttm) -2.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $32.83
Previous Close $33.43
Change ($) -0.60
Change (%) -1.79%
Day's Open 34.02
Day's Range 32.80 - 35.38
Day's Volume 35,436
52-Week Range 5.20 - 62.00

More Stats

Market Cap 378.22M
Enterprise Value 395.49M
Earnings Date (est) Aug 26, 2020
Ex-Dividend Date n/a
Shares Outstanding 11.53M
Float 5.73M
EPS (basic) n/a
EPS (diluted) -2.30
FCF / Share -0.08
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 8,859
Short Ratio 0.14
Short % of Float n/a
Beta 2.34
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 11.71
Revenue n/a
Operating Income -23.00M
Net Income -32.06M
Free Cash Flow -24.80M
Net Cash -17.27M
Net Cash / Share -1.50
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -44.20%
ROE n/a
ROIC n/a
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$30.00*
Low
30.0
Current: $32.83
High
30.0
Target: 30.00
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions ILS.

Financial Overview

Year20192018201720162015201420132012
Revenue--------
Operating Income-78.35-77.07-23.66-11.90-11.30-8.14-7.64-9.13
Net Income-109-87.73-34.55-9.18-10.20-7.76-8.04-9.33
Shares Outstanding32726120113510654.2947.9541.53
Earnings Per Share-0.33-0.34-0.17-0.07-0.10-0.14-0.17-0.22
Operating Cash Flow-77.06-57.19-10.05-9.65-10.27-7.57-4.21-7.01
Capital Expenditures-7.43-23.59-4.51-0.02-0.03-0.03-0.20-0.31
Free Cash Flow-84.49-80.79-14.56-9.67-10.30-7.60-4.40-7.31
Cash & Equivalents72.4775.8871.3825.3235.4911.6319.880.00
Total Debt13194.36------
Net Cash / Debt-58.82-18.4871.3825.3235.4911.6319.880.00
Assets11610681.7030.1141.3118.4625.82-
Liabilities18113725.444.497.761.881.84-
Book Value-65.05-31.2256.2525.6233.5516.5923.99-
Numbers in millions ILS, except per-share numbers.

Company Profile

Company Details

Full Name BiondVax Pharmaceuticals Ltd.
Country Israel
Employees 25
CEO Ronald Babecoff

Stock Information

Ticker Symbol BVXV
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: BVXV

Description

BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel. Its product candidate is M-001, a synthetic peptide-based protein, which is in Phase III clinical trials for treatment of seasonal and pandemic strains of the influenza virus. The company was founded in 2003 and is headquartered in Jerusalem, Israel.